If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSTP.L Regulatory News (STP)

  • There is currently no data for STP

Director/PDMR Shareholding

22 Jun 2018 11:00

RNS Number : 2301S
Stenprop Limited
22 June 2018
 

 

STENPROP LIMITED

(Registered in Guernsey)

(Registration number 64865)

LSE share code: STP JSE share code: STP

ISIN: GG00BFWMR296

("Stenprop" or the "Company")

 

 

DEALINGS IN SECURITIES BY A DIRECTOR OF A MAJOR SUBSIDIARY OF THE COMPANY AND ISSUE OF NEW SHARES

 

 

22 June 2018

 

Shareholders are advised of the following information relating to the acceptance of market value options awarded on 7 June 2018 under the Stenprop Limited Long Term Incentive Plan ("Long Term Incentive Plan"). The market value options will vest in three tranches on 31 March 2019, 31 March 2020 and 31 March 2021 and once fully vested will result in the issue of 95 816 shares subject to the payment of the exercise price of £1.10 per share, for a deemed value of £105 397.60.

 

Name of director:

Name of subsidiary companies:

Nicolaas Marais

Stenprop (UK) Limited and Stenprop (Germany) Limited

Transaction date:

7 June 2018

Class of securities:

Market value options

Number of securities:

95 816

Nature of transaction:

Nature and extent of director's interest:

Clearance to deal received:

Off-market acceptance of market value options in terms of the Long Term Incentive Plan

Direct beneficial

Yes

 

Shareholders are further advised of the following information relating to the acceptance of nil cost options awarded on 7 June 2018 under the Stenprop Limited Amended Deferred Share Bonus Plan ("Deferred Bonus Plan"). One third of these nil cost options vested immediately, with the second third vesting on 31 March 2019 and the last third vesting on 31 March 2020. Once fully vested, they will result in the issue of 18 363 shares.

 

Name of director:

Name of subsidiary companies:

Nicolaas Marais

Stenprop (UK) Limited and Stenprop (Germany) Limited

Transaction date:

7 June 2018

Class of securities:

Nil cost options

Number of securities:

18 363

Nature of transaction:

Nature and extent of director's interest:

Clearance to deal received:

Off-market acceptance of nil cost options in terms of the Deferred Bonus Plan

Direct beneficial

Yes

 

Shareholders are further advised of the exercise of nil cost options awarded under the Deferred Bonus Plan, comprising 6 121 nil cost options granted on 7 June 2018, which vested immediately, 3 675 options awarded on 8 June 2017 which vested on31 March 2018 and 5 283 options awarded on 9 June 2016 which vested on 31 March 2018, which will result in the issuance of 15 079 shares, in each case at a deemed value of £1.185 per share.

 

Name of director:

Name of subsidiary companies:

Nicolaas Marais

Stenprop (UK) Limited and Stenprop (Germany) Limited

Transaction date:

20 June 2018

Class of securities:

Nil cost options

Number of securities:

15 079

Deemed total value:

Nature of transaction:

Nature and extent of director's interest:

Clearance to deal received:

£17,868.61

Off-market exercise of nil cost options in terms of the Deferred Bonus Plan

Direct beneficial

Yes

 

Following the transaction, Nicolaas Marais' beneficial interest in the Company is 295 679 shares, representing approximately 0.10% of the issued capital of the Company.

 

ISSUE OF NEW SHARES

 

Application has been made for 50 819 new ordinary shares to be admitted to the Specialist Fund Segment of the London Stock Exchange and to the Main Board of the JSE. This application includes the above 15 079 vested options exercised by Nicolaas Marais and an additional 35 740 ordinary shares in relation to the exercise of additional nil cost options by an employee of the Stenprop group in terms of the Deferred Bonus Plan. It is expected that admission will take place at 8.00 am on 26 June 2018.

 

 

 

Enquiries:

 

Stenprop Limited

Paul ArensonPatsy WatsonJulian Carey

+44(0)20 7079 6600

 

Numis Securities Limited (Financial Adviser)

Hugh JonathanVicki Paine

+44(0)20 7260 1000

 

Tavistock (PR adviser)

James Whitmore

James Verstringhe

Kirsty Allan

+44(0)20 7920 3150

 

JSE Sponsor

Java Capital Trustees and Sponsors Proprietary Limited

+ 27 (0) 11 722 3050

 

About Stenprop

Stenprop is a Guernsey-registered UK REIT. The objective of the Company is to deliver sustainable growing income to its investors. Stenprop's investment policy is to invest in a diversified portfolio of UK multi-let industrial (MLI) properties with the strategic goal of becoming the leading MLI business in the UK. For further information, go to www.stenprop.com.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFKBDPOBKKFAB
Date   Source Headline
13th Feb 20207:00 amRNSPortfolio Update
5th Feb 202012:30 pmRNSTransaction in Own Shares
29th Jan 202012:00 pmRNSDirector/PDMR Shareholding
27th Jan 20203:00 pmRNSPosting of circular and notice of general meeting
14th Jan 20207:00 amRNSScrip dividend finalisation
30th Dec 20197:00 amRNSDirector/PDMR Shareholding
20th Dec 201910:00 amRNSDirector/PDMR Shareholding
19th Dec 20192:30 pmRNSElection to receive cash or scrip dividend
18th Dec 201912:00 pmRNSDisposal of Bleichenhof
22nd Nov 20197:01 amRNSSummarised half-year report
22nd Nov 20197:00 amRNSHalf-year Report
8th Nov 201912:00 pmRNSNotice of Results
25th Oct 20197:00 amRNSTrading update
18th Oct 20197:00 amRNSAcquisition of multi-let industrial estates
26th Sep 20197:00 amRNSAcquisition of multi-let industrial properties
20th Sep 20193:45 pmRNSResult of AGM
20th Sep 20197:00 amRNSAcquisition of multi-let industrial estates
6th Sep 201911:00 amRNSDirector/PDMR Shareholding
22nd Aug 201910:00 amRNSDirector/PDMR Shareholding
16th Aug 201910:00 amRNSDirector/PDMR Shareholding
15th Aug 20197:00 amRNSResult of election for cash or scrip dividend
9th Aug 20199:00 amRNSTransaction in Own Shares
6th Aug 20197:00 amRNSTrading update
2nd Aug 20193:30 pmRNSTransaction in Own Shares
31st Jul 20193:00 pmRNSNotice of AGM
19th Jul 20197:00 amRNSTRANSACTION IN OWN SHARES
18th Jul 20197:00 amRNSTransaction in Own Shares
16th Jul 201910:00 amRNSELECTION TO RECEIVE A CASH OR A SCRIP DIVIDEND
10th Jul 20198:00 amRNSDirector/PDMR Shareholding - amendment
9th Jul 20193:00 pmRNSScrip dividend circular
8th Jul 20192:00 pmRNSDirector/PDMR Shareholding
27th Jun 20193:00 pmRNSPosting of annual report and no change statement
10th Jun 20193:45 pmRNSDirector/PDMR Shareholding
6th Jun 20197:00 amRNSFinal Results
5th Jun 20193:30 pmRNSAppointment of interim CFO
17th May 20197:00 amRNSNotice of Results
3rd Apr 201912:00 pmRNSDirector/PDMR Shareholding
3rd Apr 20197:00 amRNSAppointment of JSE-accredited auditor
14th Mar 20192:45 pmRNSTransaction in Own Shares
14th Mar 20197:00 amRNSCompletion of disposal of Euston House
13th Mar 201911:00 amRNSTransaction in Own Shares
12th Mar 20191:00 pmRNSDirector/PDMR Shareholding
12th Mar 20197:00 amRNSAcquisition of multi-let industrial estate
11th Mar 201910:00 amRNSTransaction in Own Shares
8th Mar 201910:00 amRNSTransaction in Own Shares
28th Feb 20197:00 amRNSTransaction in Own Shares
13th Feb 20197:00 amRNSTransaction in Own Shares
12th Feb 20191:00 pmRNSDEALING IN SECURITIES BY DIRECTOR OF THE COMPANY
12th Feb 20197:00 amRNSTransaction in Own Shares
11th Feb 20197:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.